Hypocalcemia News and Research

RSS
Large clinical study reveals the performance of Natera's Panorama® non-invasive prenatal test

Large clinical study reveals the performance of Natera's Panorama® non-invasive prenatal test

Thyroid cancer surgery complications higher than previously thought, study suggests

Thyroid cancer surgery complications higher than previously thought, study suggests

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Study provides new insights into molecular basis of CaSR-related human diseases

Study provides new insights into molecular basis of CaSR-related human diseases

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Standardized treatment approach makes outpatient thyroid surgery a safe option for elderly patients

Standardized treatment approach makes outpatient thyroid surgery a safe option for elderly patients

Latest ENT research to be presented at AAO-HNSF's annual meeting

Latest ENT research to be presented at AAO-HNSF's annual meeting

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints